Monopar Therapeutics Inc. · NASDAQ:MNPR

Robinson Chandler exercised options for 12,873 Monopar Therapeutics Inc. shares (Form 4)

Traded Jun 30, 2026 · Filed Jul 2, 2026

On Jun 30, 2026, Robinson Chandler (Director, Chief Executive Officer) exercised options for 12,873 Monopar Therapeutics Inc. shares, leaving 99,267 shares. Filed Jul 2, 2026 (Form 4).

Options exercised
12,873 shares
Holding after
99,267 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 30, 2026Common StockOption exercise12,873103,351Direct
Jun 30, 2026Common StockShares withheld for tax4,084US$92.5999,267Direct

Source

View original at SEC

Related